... ]. For clinical use, there are also ethical concerns and questions on their tumorigenic potential. Use of iPSCs has also widely increased for a variety of regenerative medicine applications [ 20 ]. They have the advantages of unlimited cell quantity, vascular lineage-specific differentiation, patient-specific...

..., degenerative and inflammatory joint disorders. Correspondence: Dr Cosimo De Bari (email [email protected] ). 10 4 2007 14 5 2007 16 5 2007 © The Authors Journal compilation © 2007 Biochemical Society 2007 arthritis cartilage repair inflammation regenerative medicine...

... cardiovascular system hepatocyte growth factor (HGF) ischaemia prostacyclin regenerative medicine vascular endothelial growth factor (VEGF) Therapeutic angiogenesis has emerged as a promising therapy to treat ischaemic cardiovascular diseases [ 1 ]. Administration of growth factors as genes...